These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20038454)

  • 41. Radiolabelled probes targeting infection and inflammation for personalized medicine.
    Signore A; Lauri C; Galli F
    Curr Pharm Des; 2014; 20(14):2338-45. PubMed ID: 24025100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulatory Forum Opinion Piece*: Veterinary Pathologists in Translational Pharmacology and Biomarker Integration in Drug Discovery and Development.
    Ramaiah SK; Walker DB
    Toxicol Pathol; 2016 Feb; 44(2):137-46. PubMed ID: 26839329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of bioinformatics in diabetes drug development--and precision medicine.
    Dangi-Garimella S
    Am J Manag Care; 2014 May; 20(8 Spec No.):E1. PubMed ID: 25617937
    [No Abstract]   [Full Text] [Related]  

  • 44. [Differential indications for various radioactive medications for several inflammatory diseases].
    Becker W
    Nuklearmedizin; 1999; 38(6A):243. PubMed ID: 10510819
    [No Abstract]   [Full Text] [Related]  

  • 45. Biomarker discovery in asthma and COPD by proteomic approaches.
    Rossi R; De Palma A; Benazzi L; Riccio AM; Canonica GW; Mauri P
    Proteomics Clin Appl; 2014 Dec; 8(11-12):901-15. PubMed ID: 25186471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bridging the translational innovation gap through good biomarker practice.
    van Gool AJ; Bietrix F; Caldenhoven E; Zatloukal K; Scherer A; Litton JE; Meijer G; Blomberg N; Smith A; Mons B; Heringa J; Koot WJ; Smit MJ; Hajduch M; Rijnders T; Ussi A
    Nat Rev Drug Discov; 2017 Sep; 16(9):587-588. PubMed ID: 28450744
    [No Abstract]   [Full Text] [Related]  

  • 47. Systems biology and theranostic approach to drug discovery and development to treat traumatic brain injury.
    Zhang Z; Larner SF; Kobeissy F; Hayes RL; Wang KK
    Methods Mol Biol; 2010; 662():317-29. PubMed ID: 20824479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of Multiplex Biomarker Approaches to Accelerate Drug Discovery and Development.
    Rahmoune H; Guest PC
    Methods Mol Biol; 2017; 1546():3-17. PubMed ID: 27896754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective.
    Feng Z; Prentice R; Srivastava S
    Pharmacogenomics; 2004 Sep; 5(6):709-19. PubMed ID: 15335291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Urine biomarkers in the early stages of diseases: current status and perspective.
    Jing J; Gao Y
    Discov Med; 2018 Feb; 25(136):57-65. PubMed ID: 29579412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. General overview: biomarkers in neuroscience research.
    Filiou MD; Turck CW
    Int Rev Neurobiol; 2011; 101():1-17. PubMed ID: 22050846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translatability: what does it mean in drug discovery?
    Tudor M; Hermes J; Li J
    Drug Discov Today; 2016 Jun; 21(6):865-7. PubMed ID: 27021791
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrating new approaches for clinical development: translational research and relative effectiveness.
    Lehner JP; Epstein RS; Salimi T
    J Comp Eff Res; 2012 Jan; 1(1 Suppl):15-21. PubMed ID: 24237318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipidomics applications for disease biomarker discovery in mammal models.
    Zhao YY; Cheng XL; Lin RC; Wei F
    Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteomics approaches for myeloid leukemia drug discovery.
    Kapoor I; Pal P; Lochab S; Kanaujiya JK; Trivedi AK
    Expert Opin Drug Discov; 2012 Dec; 7(12):1165-75. PubMed ID: 22971110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Composite sequence proteomic analysis of protein biomarkers of Campylobacter coli, C. lari and C. concisus for bacterial identification.
    Fagerquist CK; Yee E; Miller WG
    Analyst; 2007 Oct; 132(10):1010-23. PubMed ID: 17893805
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Why clinical translation cannot succeed without failure.
    London AJ; Kimmelman J
    Elife; 2015 Nov; 4():e12844. PubMed ID: 26599839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of imaging for translational research in bone tumors.
    Benassi MS; Rimondi E; Balladelli A; Ghinelli C; Magagnoli G; Vanel D
    Eur J Radiol; 2013 Dec; 82(12):2115-23. PubMed ID: 22197732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.